A detailed history of Cynosure Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Cynosure Management, LLC holds 36,232 shares of DXCM stock, worth $2.91 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
36,232
Previous 3,210 1028.72%
Holding current value
$2.91 Million
Previous $363,000 568.87%
% of portfolio
0.36%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $2.11 Million - $3.83 Million
33,022 Added 1028.72%
36,232 $2.43 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $96,300 - $122,612
873 Added 37.36%
3,210 $363,000
Q1 2024

May 10, 2024

BUY
$114.22 - $140.1 $266,932 - $327,413
2,337 New
2,337 $324,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Cynosure Management, LLC Portfolio

Follow Cynosure Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cynosure Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cynosure Management, LLC with notifications on news.